Constella 290 mcg (Linaclotide CAPSULE) 290 MCG

Constella 290 mcg capsules contain linaclotide, a medication used to manage irritable bowel syndrome with constipation (IBS-C). This prescription treatment helps alleviate symptoms like abdominal pain and bloating.

Strength

290 MCG

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Constella 290 mcg capsules are primarily used for the treatment of irritable bowel syndrome with constipation (IBS-C). This medication works by targeting the underlying causes of IBS-C, such as abdominal pain, bloating, and discomfort. People often ask, 'What is linaclotide used for?' and the answer is that it helps to regulate bowel movements and improve overall digestive health.

Side Effects

Common effects of Constella 290 mcg capsules may include diarrhea, abdominal pain, and nausea. Some users might experience headaches or dizziness. These effects vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Constella 290 mcg capsules should be handled with care. Store them in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and pets. Always follow the advice of a healthcare professional regarding the use of this medication.

Avoid Interactions

Constella 290 mcg capsules may interact with certain medications, including other digestive aids or laxatives. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the way this medication works.

Frequently Asked Questions

Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C), helping to relieve symptoms like abdominal pain and bloating.

Constella 290 mcg capsules are taken orally, typically once daily. Follow the instructions provided by your healthcare professional.

Common side effects may include diarrhea, abdominal pain, and nausea. Always consult a healthcare professional for personalized advice.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Linaclotide can be purchased from licensed online pharmacies. Ensure you are buying from a reputable source.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.